SGSusanna Giordano

Susanna Giordano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Susanna Giordano has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An Observational Study of MDR Hospital-Acquired Infections and Antibiotic Use during COVID-19 Pandemic: A Call for Antimicrobial Stewardship Programs

    by Nour Shbaklo, Silvia Corcione, Costanza Vicentini, Susanna Giordano, Denise Fiorentino, Gabriele Bianco, Francesco Cattel, Rossana Cavallo, Carla Maria Zotti, Francesco Giuseppe De Rosa

    The pandemic caused by the COVID-19 virus has required major adjustments to healthcare systems, especially to infection control and antimicrobial stewardship. The objective of this study was to describe the incidence of multidrug-resistant (MDR) hospital-acquired infections (HAIs) and antibiotic consumption during the three waves of COVID-19 and to compare it to the period before the outbreak at Molinette Hospital, located in the City of Health and Sciences, a 1200-bed teaching hospital with surgical, medical, and intensive care units. We demonstrated an increase in MDR infections: particularly in K. pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp), A. baumannii, and MRSA. Fluoroquinolone use showed a significant increasing trend in the pre-COVID period but saw a significant reduction in the COVID period. The use of fourth- and fifth-generation cephalosporins and piperacillin–tazobactam increased at the beginning of the COVID period. Our findings support the need for restoring stewardship and infection control practices, specifically source control, hygiene, and management of invasive devices. In addition, our data reveal the need for improved microbiological diagnosis to guide appropriate treatment and prompt infection control during pandemics. Despite the infection control practices in place during the COVID-19 pandemic, invasive procedures in critically ill patients and poor source control still increase the risk of HAIs caused by MDR organisms.


  • Open Access

    Vaccine development and technology for SARS‐CoV‐2: Current insight

    by Luigi Cattel, Susanna Giordano, Sara Traina, Tommaso Lupia, Silvia Corcione, Lorenzo Angelone, Giovanni La Valle, Francesco Giuseppe De Rosa, Francesco Cattel

    Severe acute respiratory syndrome coronavirus 2 is associated with a severe respiratory disease in China, that rapidly spread across continents. Since the beginning of the pandemic, available data suggested the asymptomatic transmission and patients were treated with specific drugs with efficacy and safety data not always satisfactory. The aim of this review is to describe the vaccines developed by three companies, Pfizer‐BioNTech, Moderna, and University of Oxford/AstraZeneca, in terms of both technological and pharmaceutical formulation, safety, efficacy, and immunogenicity. A critical analysis of Phases 1, 2, and 3 clinical trial results available was conducted, comparing the three vaccine candidates, underlining their similarities and differences. All candidates showed consistent efficacy and tolerability; although some differences can be noted, such as their technological formulation, temperature storage, which will be related to logistics and costs. Further studies will be necessary to evaluate long‐term effects and to assess the vaccine safety and efficacy in the general population.


  • Ozone therapy in COVID-19: A narrative review

    by Francesco Cattel, Susanna Giordano, Cecilia Bertiond, Tommaso Lupia, Silvia Corcione, Matilde Scaldaferri, Lorenzo Angelone, Francesco Giuseppe De Rosa


  • Open Access

    Ruthenium polypyridyl squalene derivative: A novel self-assembling lipophilic probe for cellular imaging

    by Franco Dosio, Barbara Stella, Annalisa Ferrero, Claudio Garino, Daniele Zonari, Silvia Arpicco, Luigi Cattel, Susanna Giordano, Roberto Gobetto